The Diabetes Drug Market, valued at USD 53.1 billion in 2022, is set for significant growth over the next decade. It is projected to reach USD 77.3 billion by 2030, expanding at a compound annual growth rate (CAGR) of 4.9% from 2023 to 2030. The increasing prevalence of diabetes worldwide, coupled with advancements in drug development and delivery systems, is driving the market expansion....